Antimüllerian hormone levels and antral follicle counts are not reduced compared with community controls in patients with rigorously defined unexplained.

Slides:



Advertisements
Similar presentations
Validation of a prediction model for the follicle-stimulating hormone response dose in women with polycystic ovary syndrome  Madelon van Wely, Ph.D.,
Advertisements

Diminished ovarian reserve as measured by means of baseline follicle-stimulating hormone and antral follicle count is not associated with pregnancy loss.
Yuqian Cui, M. D. , Ph. D. , Yuhua Shi, M. D. , Ph. D. , Linlin Cui, M
Male infertility: a biomarker of individual and familial cancer risk
Predictors of pregnancy and live-birth in couples with unexplained infertility after ovarian stimulation–intrauterine insemination  Karl R. Hansen, M.D.,
Age at menarche: a predictor of diminished ovarian function?
Antral follicle count (AFC) can be used in the prediction of ovarian response but cannot predict the oocyte/embryo quality or the in vitro fertilization.
Karl R. Hansen, M. D. , Ph. D. , George M. Hodnett, M. D
The relative effects of hormones and relationship factors on sexual function of women through the natural menopausal transition  Lorraine Dennerstein,
Bjørn Bay, M. D. , Erik Lykke Mortensen, M. Sc
Michael M. Alper, M.D.  Fertility and Sterility 
The association between circulating levels of antimüllerian hormone and follicle number, androgens, and menstrual cycle characteristics in young women 
Mike Ripley, M. D. , F. R. C. S. C. , Andrea Lanes, M. Sc
Janet Kwee, M. D. , Roel Schats, M. D. , Ph. D. , Joseph McDonnell, M
Ramifications of adolescent menstrual cycles ≥42 days in young adults
Patient-tailored ovarian stimulation for in vitro fertilization
Ethnicity as a determinant of ovarian reserve: differences in ovarian aging between Spanish and Indian women  Carlos Iglesias, M.D., Manish Banker, M.D.,
Antimüllerian hormone levels and antral follicle count as prognostic indicators in a personalized prediction model of live birth  Scott M. Nelson, M.R.C.O.G.,
The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count  Simone L. Broer, B.Sc., Ben Willem J.
Impact of breast cancer chemotherapy on ovarian reserve: a prospective observational analysis by menstrual history and ovarian reserve markers  Andrea.
Hakan Cakmak, M. D. , Audra Katz, R. N. , Marcelle I. Cedars, M. D
How old is too old? Challenges faced by clinicians concerning age cutoffs for patients undergoing in vitro fertilization  Robert L. Klitzman, M.D.  Fertility.
Antral follicle count: absence of significant midlife decline
The role of steroid hormone supplementation in non–assisted reproductive technology treatments for unexplained infertility  Alexander M. Quaas, M.D.,
Triploidy formation after intracytoplasmic sperm injection may be a surrogate marker for implantation  Mitchell P. Rosen, M.D., Shehua Shen, M.D., Anthony.
Diminished ovarian reserve as measured by means of baseline follicle-stimulating hormone and antral follicle count is not associated with pregnancy loss.
Improved monofollicular ovulation in anovulatory or oligo-ovulatory women after a low- dose step-up protocol with weekly increments of 25 international.
Increased risk of incident chronic medical conditions in infertile men: analysis of United States claims data  Michael L. Eisenberg, M.D., Shufeng Li,
Evaluating the performance of serum antimullerian hormone concentration in predicting the live birth rate of controlled ovarian stimulation and intrauterine.
Do anti-mullerian hormone levels predict ovarian reserve in SLE patients presenting for hematopoietic stem cell transplant?  H. Browne, A. Armstrong,
Clinical course of depression symptoms and predictors of enduring depression risk in women with polycystic ovary syndrome: Results of a longitudinal study 
Modification of the Beckman-Coulter second-generation enzyme-linked immunosorbent assay protocol improves the reliability of serum antimüllerian hormone.
Albert Hsu, M. D. , Margaret Arny, Ph. D. , Alexander B. Knee, M. S
Gadolinium radiologic contrast is a useful alternative for hysterosalpingography in patients with iodine allergy  Dorette Noorhasan, M.D., Michael J.
Raising threshold for diagnosis of polycystic ovary syndrome excludes population of patients with metabolic risk  Molly M. Quinn, M.D., Chia-Ning Kao,
The Pregnancy in Polycystic Ovary Syndrome II study: baseline characteristics and effects of obesity from a multicenter randomized clinical trial  Richard.
Race/ethnic disparities in reproductive age: an examination of ovarian reserve estimates across four race/ethnic groups of healthy, regularly cycling.
Links between age at menarche, antral follicle count, and body mass index in African American and European American women  Sonya M. Schuh, Ph.D., Julia.
A comparison of three downregulation approaches for poor responders undergoing in vitro fertilization  Laura Detti, M.D., Daniel B. Williams, M.D., Jared.
A new approach to ovarian reserve testing
Benny Almog, M. D. , Fady Shehata, M. B. , B. Ch. , M. Sc
Patients with severe ovarian hyperstimulation syndrome can be managed safely with aggressive outpatient transvaginal paracentesis  Laura P. Smith, M.D.,
Impact of pituitary suppression on antral follicle count and oocyte recovery after ovarian stimulation  Nam D. Tran, M.D., Ph.D., Lusine Aghajanova, M.D.,
Tomer Singer, M. D. , David H. Barad, M. D. , M. S
Male infertility: a biomarker of individual and familial cancer risk
Mitchell P. Rosen, M. D. , Erica Johnstone, M. D. , Charles E
Inequity between male and female coverage in state infertility laws
Akanksha Mehta, M.D., Darius A. Paduch, M.D., Ph.D. 
Antimüllerian hormone and antral follicle count are lower in female cancer survivors and healthy women taking hormonal contraception  Lauren N.C. Johnson,
Evaluation of diagnostic testis biopsy and the repetition of testicular sperm extraction surgeries in infertility patients  Alayman Hussein, M.B.B.C.H.,
Sources of heterogeneities in estimating the prevalence of endometriosis in infertile and previously fertile women  Sun-Wei Guo, Ph.D., Yuedong Wang,
“Information-rich” reproductive outcomes in carriers of a structural chromosome rearrangement ascertained on the basis of recurrent pregnancy loss  Michelle.
Urinary triclosan concentrations and diminished ovarian reserve among women undergoing treatment in a fertility clinic  Lidia Mínguez-Alarcón, Ph.D.,
Michael C. Allemand, M. D. , Ian S. Tummon, M. D. , Jennifer L. Phy, D
Simple tools for assessment of ovarian reserve (OR): individual ovarian dimensions are reliable predictors of OR  Stacea Bowen, M.D., John Norian, M.D.,
Vasiliki A. Moragianni, M. D. , M. S. , Stephanie-Marie L. Jones, M. D
Cameron Gilbert, M. Sc. , Maria Valois, M. D. , FRCPC, Ph. D
Pregnancy outcome in infertile patients with polycystic ovary syndrome who were treated with metformin  Samuel S. Thatcher, M.D., Ph.D., Elizabeth M.
Antimüllerian hormone in gonadotropin releasing-hormone antagonist cycles: prediction of ovarian response and cumulative treatment outcome in good-prognosis.
Ovarian expression of markers associated with proliferation or apoptosis in women with diminished ovarian reserve  Víctor Vital-Reyes, M.D., M.Sc., Cristina.
Antral follicle counts are strongly associated with live-birth rates after assisted reproduction, with superior treatment outcome in women with polycystic.
Validation of a prediction model for the follicle-stimulating hormone response dose in women with polycystic ovary syndrome  Madelon van Wely, Ph.D.,
A woman with premature ovarian failure induced by Tripterygium wilfordii Hook.f. gives birth to a healthy child  Xin Chen, M.D., M.Sc., Shi-ling Chen,
Nomogram for the decline in serum antimüllerian hormone: a population study of 9,601 infertility patients  Scott M. Nelson, Ph.D., Martina C. Messow,
Aline Ketefian, M. D. , Jianfang Hu, Ph. D. , Alfred A. Bartolucci, Ph
Egg production predicts a doubling of in vitro fertilization pregnancy rates even within defined age and ovarian reserve categories  Melissa C. Yih, M.D.,
Cem Fiçicioǧlu, M. D. , Tayfun Kutlu, M. D. , Elif Baglam, M. D
Brooks A. Keel, Ph.D., H.C.L.D.(A.B.B.)  Fertility and Sterility 
A novel “delayed start” protocol with gonadotropin-releasing hormone antagonist improves outcomes in poor responders  Hakan Cakmak, M.D., Nam D. Tran,
A prospective, comparative analysis of anti-Müllerian hormone, inhibin-B, and three- dimensional ultrasound determinants of ovarian reserve in the prediction.
Presentation transcript:

Antimüllerian hormone levels and antral follicle counts are not reduced compared with community controls in patients with rigorously defined unexplained infertility  Eleni A. Greenwood, M.D., M.Sc., Marcelle I. Cedars, M.D., Nanette Santoro, M.D., Esther Eisenberg, M.D., M.P.H., Chia-Ning Kao, M.Sc., Daniel J. Haisenleder, Ph.D., Michael P. Diamond, M.D., Heather G. Huddleston, M.D.  Fertility and Sterility  Volume 108, Issue 6, Pages 1070-1077 (December 2017) DOI: 10.1016/j.fertnstert.2017.09.015 Copyright © 2017 American Society for Reproductive Medicine Terms and Conditions

Figure 1 Antimüllerian hormone and AFC by age. Unadjusted whisker plots of ovarian reserve measures by age group. Fertility and Sterility 2017 108, 1070-1077DOI: (10.1016/j.fertnstert.2017.09.015) Copyright © 2017 American Society for Reproductive Medicine Terms and Conditions

Figure 2 Antimüllerian hormone, AFC, and AMH/AFC predicted models. Solid lines display predicted outcome effects. Models are controlled for age, race, BMI, smoking history, and study site. The 95% confidence intervals, depicted by dotted lines, are calculated for infertility effect only. Fertility and Sterility 2017 108, 1070-1077DOI: (10.1016/j.fertnstert.2017.09.015) Copyright © 2017 American Society for Reproductive Medicine Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2024 SlidePlayer.com. Inc. All rights reserved.